Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device Protrusion

Marcello Giudice; Bruna Catuzzo; Nicola Berlier; Ernest W Lau; Hendrik Bonnemeier; Ojan Assadian; Benito Baldauf; Stefan Borov; Paolo Scacciatella

doi:10.1016/j.jaccas.2023.101835

Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device Protrusion

JACC Case Rep. 2023 Apr 19:14:101835. doi: 10.1016/j.jaccas.2023.101835. eCollection 2023 May 17.

Authors

Marcello Giudice¹, Bruna Catuzzo¹, Nicola Berlier¹, Ernest W Lau², Hendrik Bonnemeier^{3

4

5}, Ojan Assadian⁶, Benito Baldauf⁵, Stefan Borov^{5

7}, Paolo Scacciatella¹

Affiliations

¹ Department for Cardiology and Electrophysiology, U. Parini Hospital, Aosta, Italy.
² Royal Victoria Hospital, Belfast, United Kingdom.
³ Helios Klinikum Cuxhaven, Cuxhaven, Germany.
⁴ Helios Klinikum Wesermarsch, Nordenham, Germany.
⁵ Christian-Albrechts University, Kiel, Germany.
⁶ Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria.
⁷ Lakumed Kliniken, Landshut, Germany.

Abstract

We report the successful salvage of cardiac implantable electronic device pulse generator protrusion sealed by the surrounding skin in a frail patient presenting 5 months after the last surgical revision. (Level of Difficulty: Advanced.).

Keywords: cardiac implantable electronic device; fistula; infection; lead extraction; salvage; skin erosion; taurolidine.

Publication types

Case Reports